Clinical Trials
9 trialsNCT04660929 2024-12-18
CAR-macrophages for the Treatment of HER2 Overexpressing Solid Tumors
Carisma Therapeutics Inc
Phase 1 Unknown
NCT05872867 2024-03-12
MK-3475-E90
Wellmarker Bio
Phase 1 Unknown
NCT03532737 2024-01-23
Concomitant Immune Check Point Inhibitor With Radiochemotherapy in Head And Neck Cancer
Kuwait Cancer Control Center
Phase 2 Unknown
NCT05708950 2023-07-13
A Clinical Trial of KVA12123 Treatment Alone and in Combination With Pembrolizumab In Advanced Solid Tumors (VISTA-101)
Kineta Inc.
Phase 1/2 Unknown
NCT04359199 2023-02-10
QUASAR
University of California, San Diego
Unknown
NCT05551767 2022-09-23
Induction Immunochemotherapy in Stage III-IVa Head and Neck Cancer
City Clinical Oncology Hospital No 1
Phase 2 Unknown
NCT04460456 2022-06-30
A Study of SBT6050 Alone and in Combination With PD-1 Inhibitors in Subjects With Advanced HER2 Expressing Solid Tumors
Silverback Therapeutics
Phase 1 Unknown
NCT04740996 2022-02-07
Study of Pembrolizumab in the First Line Therapy for R/M HNSCC in China
ChineseAMS
Unknown
NCT04999800 2021-08-11
Study of Pembrolizumab Combined With Anlotinib in the First Line Therapy for R/M HNSCC With CPS≥1
ChineseAMS
Phase 2 Unknown